Compare Unichem Lab with Lupin Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs LUPIN - Comparison Results

LUPIN 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB LUPIN UNICHEM LAB/
LUPIN
 
P/E (TTM) x -87.3 -78.4 - View Chart
P/BV x 0.5 2.3 20.5% View Chart
Dividend Yield % 2.9 0.0 -  

Financials

 UNICHEM LAB   LUPIN
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
LUPIN
Mar-19
UNICHEM LAB/
LUPIN
5-Yr Chart
Click to enlarge
High Rs292986 29.6%   
Low Rs182720 25.3%   
Sales per share (Unadj.) Rs167.7369.5 45.4%  
Earnings per share (Unadj.) Rs-3.613.4 -27.1%  
Cash flow per share (Unadj.) Rs5.937.4 15.9%  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %1.70-  
Book value per share (Unadj.) Rs372.3303.7 122.6%  
Shares outstanding (eoy) m70.38452.49 15.6%   
Bonus/Rights/Conversions ESOPESOP-  
Price / Sales ratio x1.42.3 61.2%   
Avg P/E ratio x-65.363.6 -102.6%  
P/CF ratio (eoy) x39.922.8 174.8%  
Price / Book Value ratio x0.62.8 22.7%  
Dividend payout %-110.20-   
Avg Mkt Cap Rs m16,680386,064 4.3%   
No. of employees `0002.617.7 14.7%   
Total wages/salary Rs m2,39331,513 7.6%   
Avg. sales/employee Rs Th4,535.29,453.8 48.0%   
Avg. wages/employee Rs Th919.81,782.0 51.6%   
Avg. net profit/employee Rs Th-98.2343.0 -28.6%   
INCOME DATA
Net Sales Rs m11,801167,182 7.1%  
Other income Rs m9843,640 27.0%   
Total revenues Rs m12,785170,822 7.5%   
Gross profit Rs m-83528,822 -2.9%  
Depreciation Rs m67410,850 6.2%   
Interest Rs m753,078 2.4%   
Profit before tax Rs m-60018,534 -3.2%   
Minority Interest Rs m0-89 0.0%   
Prior Period Items Rs m138 1.9%   
Extraordinary Inc (Exp) Rs m0-3,400 0.0%   
Tax Rs m-3439,017 -3.8%   
Profit after tax Rs m-2566,066 -4.2%  
Gross profit margin %-7.117.2 -41.0%  
Effective tax rate %57.348.7 117.7%   
Net profit margin %-2.23.6 -59.7%  
BALANCE SHEET DATA
Current assets Rs m20,384138,536 14.7%   
Current liabilities Rs m5,02961,299 8.2%   
Net working cap to sales %130.146.2 281.7%  
Current ratio x4.12.3 179.3%  
Inventory Days Days10584 125.1%  
Debtors Days Days135112 120.0%  
Net fixed assets Rs m9,023127,516 7.1%   
Share capital Rs m141905 15.6%   
"Free" reserves Rs m26,058136,517 19.1%   
Net worth Rs m26,199137,422 19.1%   
Long term debt Rs m066,417 0.0%   
Total assets Rs m31,496279,494 11.3%  
Interest coverage x-7.07.0 -99.3%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.40.6 62.6%   
Return on assets %-0.63.3 -17.5%  
Return on equity %-1.04.4 -22.1%  
Return on capital %-2.08.9 -22.4%  
Exports to sales %69.40-   
Imports to sales %00-   
Exports (fob) Rs m8,188NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m8,18859,414 13.8%   
Fx outflow Rs m59622,282 2.7%   
Net fx Rs m7,59237,132 20.4%   
CASH FLOW
From Operations Rs m-3,27816,660 -19.7%  
From Investments Rs m-2,860-32,825 8.7%  
From Financial Activity Rs m-247,441 -0.3%  
Net Cashflow Rs m-4,690-8,724 53.8%  

Share Holding

Indian Promoters % 50.1 46.6 107.5%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 15.1 11.3 133.6%  
FIIs % 3.0 31.9 9.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 10.1 313.9%  
Shareholders   20,176 98,259 20.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   ALEMBIC LTD  AUROBINDO PHARMA  IPCA LABS  GLENMARK PHARMA  SUN PHARMA  

Compare UNICHEM LAB With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 428 Points Higher; Energy and Healthcare Stocks Witness Buying(Closing)

Indian share markets continued their momentum during closing hours and ended their trading session on a positive note today.

Related Views on News

LUPIN Announces Quarterly Results (2QFY20); Net Profit Down 146.4% (Quarterly Result Update)

Nov 7, 2019 | Updated on Nov 7, 2019

For the quarter ended September 2019, LUPIN has posted a net profit of Rs 1 bn (down 146.4% YoY). Sales on the other hand came in at Rs 44 bn (up 10.3% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (1QFY20); Net Profit Up 49.3% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, LUPIN has posted a net profit of Rs 3 bn (up 49.3% YoY). Sales on the other hand came in at Rs 44 bn (up 14.6% YoY). Read on for a complete analysis of LUPIN's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

More Views on News

Most Popular

This Smallcap Stock Could be the Next Titan (Up 1,400% in 10 Years)(Profit Hunter)

Feb 11, 2020

A blueprint to latch on to the next 'Crorepati' stock - and an event I hope you won't miss on any account.

How to Become a One Stock Crorepati(Profit Hunter)

Feb 6, 2020

A little known Indian stock that is set to turn around its own fortunes, and your wealth, if you just have the foresight to get in on time...

Will Algo Traders Take Away All Your Profits?(Fast Profits Daily)

Feb 11, 2020

How to fight back against algo trading systems.

How to Use Stop Losses in Your Trading(Fast Profits Daily)

Feb 13, 2020

There's more to stop losses than just limiting a trading loss. Find out more...

No Change in My Long-Term View on the Rebirth of India Stocks(The 5 Minute Wrapup)

Feb 6, 2020

Why the recent post budget volatility has not affected my bullish view on the Rebirth of India stocks.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Feb 19, 2020 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - STERLING BIOTECH COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS